Bridge City Capital LLC grew its stake in Masimo Corporation (NASDAQ:MASI) by 8.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,774 shares of the medical equipment provider’s stock after buying an additional 2,142 shares during the period. Masimo Corporation makes up about 1.7% of Bridge City Capital LLC’s holdings, making the stock its 11th biggest holding. Bridge City Capital LLC owned 0.05% of Masimo Corporation worth $2,318,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently added to or reduced their stakes in the company. Fortaleza Asset Management Inc. purchased a new position in Masimo Corporation in the 2nd quarter worth approximately $106,000. Dubuque Bank & Trust Co. grew its stake in Masimo Corporation by 3.4% in the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock worth $170,000 after buying an additional 61 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Masimo Corporation by 13.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock worth $184,000 after buying an additional 236 shares in the last quarter. Neuberger Berman Group LLC purchased a new position in Masimo Corporation in the 1st quarter worth approximately $206,000. Finally, Campbell & CO Investment Adviser LLC purchased a new position in Masimo Corporation in the 2nd quarter worth approximately $203,000. 82.96% of the stock is owned by institutional investors and hedge funds.
Masimo Corporation (NASDAQ:MASI) last posted its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.17. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.89%. The firm had revenue of $193.69 million during the quarter, compared to analyst estimates of $189.01 million. During the same period last year, the firm posted $0.52 earnings per share. Masimo Corporation’s revenue for the quarter was up 15.6% compared to the same quarter last year.
MASI has been the subject of a number of research reports. BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research note on Monday, August 14th. Stifel Nicolaus reissued a “buy” rating and issued a $108.00 price target (up previously from $105.00) on shares of Masimo Corporation in a research note on Thursday, August 3rd. Roth Capital boosted their price target on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. BidaskClub raised shares of Masimo Corporation from a “hold” rating to a “buy” rating in a research note on Wednesday, July 12th. Finally, Zacks Investment Research upgraded shares of Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 price objective for the company in a report on Thursday. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $97.17.
In related news, Director Sanford Fitch sold 11,000 shares of the firm’s stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total value of $959,750.00. Following the completion of the transaction, the director now directly owns 72,249 shares of the company’s stock, valued at $6,303,725.25. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 16.60% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://sportsperspectives.com/2017/11/02/bridge-city-capital-llc-grows-holdings-in-masimo-corporation-masi.html.
Masimo Corporation Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.